Cryo-Cell International (FRA:ZCY) Change In Payables And Accrued Expense : €0.35 Mil (TTM As of Feb. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International Change In Payables And Accrued Expense?

Cryo-Cell International's Change In Payables And Accrued Expense for the quarter that ended in Feb. 2024 was €-2.03 Mil. It means Cryo-Cell International's Accounts Payable & Accrued Expense declined by €2.03 Mil from Nov. 2023 to Feb. 2024 .

Cryo-Cell International's Change In Payables And Accrued Expense for the fiscal year that ended in Nov. 2023 was €2.10 Mil. It means Cryo-Cell International's Accounts Payable & Accrued Expense increased by €2.10 Mil from Nov. 2022 to Nov. 2023 .

Cryo-Cell International Change In Payables And Accrued Expense Historical Data

The historical data trend for Cryo-Cell International's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Change In Payables And Accrued Expense Chart

Cryo-Cell International Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.45

0.58

0.48

0.63

2.10

Cryo-Cell International Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.27	-0.43	-0.46	3.27	-2.03

Cryo-Cell International Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.35 Mil.

Cryo-Cell International Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International (FRA:ZCY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

CCEL:USA

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677

Website

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

Cryo-Cell International (FRA:ZCY) Headlines

No Headlines